Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Scientific animation of blood cells inside the lumen of a blood vessel

How and why do atherosclerotic plaques develop? Scientists already know  that turbulent blood flow patterns predispose arteries to develop plaques, but it’s been unclear how turbulence in blood vessels switches healthy endothelial cell lining into a disease state. Now, in a new study published in Science Advances, Professor Ellie Tzima’s group uses a multi-disciplinary approach to identify a molecular sensor for cellular transformation.

 In areas of turbulent flow, the healthy endothelium that lines and protects blood vessels starts transforming and transitioning into a mesenchymal phenotype, a process called endothelial-to-mesenchymal transition (EndMT). During this complex process, endothelial cells lose or reduce expression of their endothelial markers, and instead, start adopting a mesenchymal phenotype, characterised by expression of mesenchymal-specific proteins. Although EndMT is critical during embryonic development, it is also an important mechanism in the pathogenesis of several human diseases, including cancer, cardiovascular disease and even COVID-19 complications.

Professor Tzima and her team were able to identify a mechano-receptor expressed in endothelial cells that senses turbulent blood flow, and signals to set off a cascade of processes that shift cells towards this endothelial-to-mesenchymal transformation. 

 Professor Ellie Tzima said: “What is most fascinating is that application of force onto a single receptor is enough to induce a complex signalling pathway that will ultimately lead to endothelial transformation and atherosclerosis.

The role of haemodynamic forces as instigators and contributors to cardiovascular disease is now widely recognised. This study identifies novel therapeutic strategies to target the mechanobiology of endothelial cells in cardiovascular disease. “

Dr Vedanta Mehta, co-first author of the study said “It is indeed very interesting that a cellular receptor, previously only known to respond to biochemical stimuli, can also respond to mechanical forces to initiate pathological signalling that ultimately culminates in atherosclerosis.

 It is now widely appreciated that fluid forces play a major contribution towards the development of cardiovascular disorders, yet there is not a single therapy to date that targets mechanotransduction pathways to ameliorate pathogenesis. We hope that this study will pave the way for the development of novel ‘mechano-medicines’ to reduce the burden of heart disease”.

 Dr Kar Lai Pang, co-first author of the paper said: “It is intriguing that our group has discovered a novel mechanoreceptor that responds to turbulent blood flow which leads to EndMT pathophysiological process and atherosclerosis. Unveiling new novel molecular targets will enhance our understanding of disease pathways and hence development of new drugs and therapeutics approaches for the vascular disease.”

This work was undertaken in collaboration with researchers from Emory University and UNC, USA. The major funders were Wellcome and the British Heart Foundation.

Similar stories

Joaquim Vieira brings heart regeneration research to the public at Pint of Science

Pint of Science is the world’s largest public science festival bringing researchers to local pubs, cafes and spaces to share their scientific discoveries with the public.

DPAG researchers showcased at premier European Society of Cardiology meeting

DPAG scientists across four research groups were highlighted at the major annual European Society of Cardiology basic science conference (FCVB 2022). Congratulations are in order for Dr KC Park on receiving the Young Investigator Award and to Dr Elisabetta Gamen on winning the Moderated Poster Prize.

The effect of nuclear pH on cardiac gene expression

Research led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.

RDM researchers awarded £2million MRC grant

Researchers at the Cardiovascular Clinical Research Facility (CCRF) have won a five year MRC funding programme to help understand how high blood pressure (hypertension) during pregnancy affects the heart, brain and blood vessels throughout the life of women, as well as the children born after such a pregnancy.

Study indicates reasons for decline in death rates from heart attacks

A new study involving Oxford Population Health researchers finds that both prevention and improved treatments have helped reduce deaths from heart attacks - but the relative importance of each varies by country, age and sex.

Review highlights impact of Long COVID on cardiovascular system

The wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID on the cardiovascular system.